.
6118 financial statements
* Numbers in millions
Year |
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | TTM |
|---|---|---|---|---|---|---|---|---|
Capitalization * |
907 | 656 | 605 | 1 440 | 2 978 | 2 409 | 3 075 | 1 343 |
EV * |
560 | 298 | 338 | 1 178 | 2 808 | 2 276 | 2 974 | 2 974 |
Stock price ¤ |
2.3 | 1.28 | 1.18 | 2.81 | 5.81 | 4.7 | 6 | 2.62 |
Number of shares * |
394 | 513 | 513 | 513 | 513 | 513 | 513 | 513 |
EPS |
0,17 | 0,01 | -0,04 | -0,11 | 0,00 | 0,02 | 0,06 | 0,06 |
Revenue * |
680 | 628 | 673 | 547 | 817 | 1 049 | 1 296 | 1 296 |
Net income * |
65 | 6 | -19 | -54 | 0 | 8 | 33 | 33 |
Operating profit * |
85 | 3 | -21 | -69 | -6 | 7 | 35 | 35 |
Total liabilities * |
320 | 410 | 369 | 401 | 588 | 672 | 854 | 854 |
Net debt * |
-348 | -358 | -266 | -262 | -171 | -133 | -101 | -101 |
Total assets * |
869 | 961 | 915 | 882 | 1 071 | 1 174 | 1 379 | 1 379 |
Equity * |
549 | 551 | 546 | 478 | 481 | 495 | 518 | 518 |
Cash and investments * |
383 | 393 | 286 | 309 | 197 | 191 | 178 | 178 |
Over the past 10 years, the maximum capitalization of Austar Lifesciences Limited is 3 075, the minimum is 605. Maximum net income 65, Minimum net income -54. The maximum price of 6118 shares is 6, the minimum price is 1.18.
.
6118 valuation
Year |
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | TTM |
|---|---|---|---|---|---|---|---|---|
P/E |
13,92 | 102,77 | -32,40 | -26,63 | 27 832,70 | 297,76 | 92,92 | 40,57 |
P/B |
1,65 | 1,19 | 1,11 | 3,01 | 6,19 | 4,87 | 5,94 | 2,59 |
P/S |
1,33 | 1,05 | 0,90 | 2,63 | 3,65 | 2,30 | 2,37 | 1,04 |
E/P |
7% | 1% | -3% | -4% | 0% | 0% | 1% | 2% |
P/FCF |
-11,81 | 13,96 | -14,07 | -91,62 | -25,07 | 104,14 | -205,05 | -89,54 |
.
6118 profitability
Year |
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | TTM |
|---|---|---|---|---|---|---|---|---|
ROE |
12% | 1% | -3% | -11% | 0% | 2% | 6% | |
ROA |
8% | 1% | -2% | -6% | 0% | 1% | 3% | |
ROIC |
15% | 1% | -4% | -14% | -1% | 1% | 6% |